Cedar Brook Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $610K | Buy |
|
|||||
|
2023
Q4 | $548K | Buy |
|
|||||
|
2023
Q3 | $583K | Sell |
|
|||||
|
2023
Q2 | $659K | Buy |
|
|||||
|
2023
Q1 | $580K | Buy |
|
|||||
|
2022
Q4 | $498K | Buy |
|
|||||
|
2022
Q3 | $413K | Buy |
|
|||||
|
2022
Q2 | $270K | Buy |
|
|||||
|
2022
Q1 | $221K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $205K | Sell |
|
|||||
|
2021
Q1 | $202K | Sell |
|
|||||
|
2020
Q4 | $256K | Sell |
|
|||||
|
2020
Q3 | $305K | Buy |
|
|||||
|
2020
Q2 | $287K | Buy |
|
|||||
|
2020
Q1 | $228K | Sell |
|
|||||
|
2019
Q4 | $297K | Buy |
|